Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on <i>EGFR</i> -Mutant Cells

Jie Zhang(The University of Texas MD Anderson Cancer Center), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center)
Cancer Prevention Research
March 31, 2008
Cited by 86


Related Papers